Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 631326, 11 pages
http://dx.doi.org/10.1155/2015/631326
Research Article

Role of TLR4-Mediated PI3K/AKT/GSK-3β Signaling Pathway in Apoptosis of Rat Hepatocytes

1Department of Infectious Disease, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China
2Department of Infectious Disease, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China
3Department of Science Technology and Industry, Nantong University, Nantong, Jiangsu 226019, China
4Department of Pathophysiology, Nantong University, Nantong, Jiangsu 226001, China

Received 16 September 2015; Revised 9 November 2015; Accepted 17 November 2015

Academic Editor: Antoni Camins

Copyright © 2015 Xian Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Shirozu, K. Tokuda, E. Marutani, D. Lefer, R. Wang, and F. Ichinose, “Cystathionine γ-Lyase deficiency protects mice from Galactosamine/lipopolysaccharide-induced acute liver failure,” Antioxidants and Redox Signaling, vol. 20, no. 2, pp. 204–216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Kasahara, K. Saitoh, and K. Nakamura, “Apoptosis in acute hepatic failure: histopathological study of human liver tissue using the tunel method and immunohistochemistry,” Journal of Medical and Dental Sciences, vol. 47, no. 3, pp. 167–175, 2000. View at Google Scholar · View at Scopus
  3. D. X. Liu, “A new hypothesis of pathogenetic mechanism of viral hepatitis B and C,” Medical Hypotheses, vol. 56, no. 3, pp. 405–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. J. Cheng, W. C. Shyu, Y. H. Teng, Y. H. Lan, and S. D. Lee, “Antagonistic interaction between cordyceps sinensis and exercise on protection in fulminant hepatic failure,” The American Journal of Chinese Medicine, vol. 42, no. 5, pp. 1199–1213, 2014. View at Publisher · View at Google Scholar
  5. K. Ohashi, V. Burkart, S. Flohé, and H. Kolb, “Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex,” Journal of Immunology, vol. 164, no. 2, pp. 558–561, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Y. Kim, E. Jeong, S. M. Joung, and J. Y. Lee, “PI3K/Akt contributes to increased expression of Toll-like receptor 4 in macrophages exposed to hypoxic stress,” Biochemical and Biophysical Research Communications, vol. 419, no. 3, pp. 466–471, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Takayashiki, H. Yoshidome, F. Kimura et al., “Increased expression of toll-like receptor 4 enhances endotoxin-induced hepatic failure in partially hepatectomized mice,” Journal of Hepatology, vol. 41, no. 4, pp. 621–628, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. P. C. Benias, K. Gopal, H. Bodenheimer, and N. D. Theise, “Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis C,” Clinics and Research in Hepatology and Gastroenterology, vol. 36, no. 5, pp. 448–454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. D. N. Cook, D. S. Pisetsky, and D. A. Schwartz, “Toll-like receptors in the pathogenesis of human disease,” Nature Immunology, vol. 5, no. 10, pp. 975–979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Fulda, “Modulation of mitochondrial apoptosis by PI3K inhibitors,” Mitochondrion, vol. 13, no. 3, pp. 195–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. N. N. Johnson-Farley, K. Patel, D. Kim, and D. S. Cowen, “Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures,” Brain Research, vol. 1154, no. 1, pp. 40–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. E. Guicciardi and G. J. Gores, “Apoptosis as a mechanism for liver disease progression,” Seminars in Liver Disease, vol. 30, no. 4, pp. 402–410, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Wang, “Molecular mechanisms of liver injury: apoptosis or necrosis,” Experimental and Toxicologic Pathology, vol. 66, no. 8, pp. 351–356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Tagami, H. Ohnishi, and R. D. Hughes, “Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose,” Hepato-Gastroenterology, vol. 50, no. 51, pp. 742–745, 2003. View at Google Scholar · View at Scopus
  15. S.-J. Kim, K.-M. Kim, J. Park, J.-H. Kwak, Y. S. Kim, and S.-M. Lee, “Geniposidic acid protects against D-galactosamine and lipopolysaccharide-induced hepatic failure in mice,” Journal of Ethnopharmacology, vol. 146, no. 1, pp. 271–277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. M. Riordan and R. Williams, “Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure,” Seminars in Liver Disease, vol. 23, no. 3, pp. 203–215, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Jaeschke, J. S. Gujral, and M. L. Bajt, “Apoptosis and necrosis in liver disease,” Liver International, vol. 24, no. 2, pp. 85–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. L. A. Possamai, M. J. W. McPhail, A. Quaglia et al., “Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure,” Critical Care Medicine, vol. 41, no. 11, pp. 2543–2550, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Doggrell, “Suramin: potential in acute liver failure,” Expert Opinion on Investigational Drugs, vol. 13, no. 10, pp. 1361–1363, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Morio, M. Tsuji, M. Inagaki et al., “Ethanol-induced apoptosis in human liver adenocarcinoma cells (SK-Hep1): Fas- and mitochondria-mediated pathways and interaction with MAPK signaling system,” Toxicology in Vitro, vol. 27, no. 6, pp. 1820–1829, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Togo, T. Kubota, K. Matsuo et al., “Mechanism of liver failure after hepatectomy,” Nippon Geka Gakkai zasshi, vol. 105, no. 10, pp. 658–663, 2004. View at Google Scholar · View at Scopus
  22. S. T. Eichhorst, “Modulation of apoptosis as a target for liver disease,” Expert Opinion on Therapeutic Targets, vol. 9, no. 1, pp. 83–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-M. Wang, G.-H. Feng, F. Huang, Y. Li, and G.-Z. Zhao, “Tumor necrosis factor-alpha, caspase-3 expression and hepatocyte apoptosis in fulminanting hepatic failure,” Zhonghua Nei Ke Za Zhi, vol. 42, no. 8, pp. 566–570, 2003. View at Google Scholar · View at Scopus
  24. I. Herzum and H. Renz, “Inflammatory markers in SIRS, sepsis and septic shock,” Current Medicinal Chemistry, vol. 15, no. 6, pp. 581–587, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-J. Kim, H.-I. Cho, S.-J. Kim et al., “Protective effect of linarin against d-galactosamine and lipopolysaccharide-induced fulminant hepatic failure,” European Journal of Pharmacology, vol. 738, pp. 66–73, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. G. L. Su, “Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 283, no. 2, pp. G256–G265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Aksamitiene, A. Kiyatkin, and B. N. Kholodenko, “Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance,” Biochemical Society Transactions, vol. 40, no. 1, pp. 139–146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Y. Zhu, J. L. Guo, H. Xia et al., “The anti-apoptotic effect of cytoplasmic alpha-fetoprotein in hepatoma cells induced by all-trans retinoic acid involves activation of the PI3K/AKT signaling pathway,” Chinese Journal of Hepatology, vol. 22, no. 11, pp. 837–842, 2014. View at Publisher · View at Google Scholar
  29. M. Hanada, J. Feng, and B. A. Hemmings, “Structure, regulation and function of PKB/AKT—a major therapeutic target,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1697, no. 1-2, pp. 3–16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. J. Atkins, J. Dimou, L. Paradiso et al., “Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas,” Journal of Clinical Neuroscience, vol. 19, no. 11, pp. 1558–1563, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Yang, S. Xie, M. S. Jamaluddin et al., “Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells,” The Journal of Biological Chemistry, vol. 280, no. 39, pp. 33558–33565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Dai, Y. Xia, L. Mao, Y. Mei, Y. Xue, and B. Hu, “Involvement of PI3K/Akt pathway in the neuroprotective effect of Sonic hedgehog on cortical neurons under oxidative stress,” Journal of Huazhong University of Science and Technology. Medical Sciences, vol. 32, no. 6, pp. 856–860, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Y. Kim, J. U. Lee, J. H. Kim et al., “Decrease of PKB/Akt phosphorylation is partially mediated by SAPK/JNK activation in serum-free L6 myoblasts starved with low glucose,” Journal of Physical Therapy Science, vol. 26, no. 11, pp. 1757–1760, 2014. View at Publisher · View at Google Scholar
  34. G. Arboleda, L. C. Morales, B. Benítez, and H. Arboleda, “Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegeneration,” Brain Research Reviews, vol. 59, no. 2, pp. 333–346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Chen, F. Ren, H. Zhang et al., “Inhibition of glycogen synthase kinase 3beta ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis,” PLoS ONE, vol. 7, no. 9, Article ID e45202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. W. S. Lee, S. M. Yi, J. W. Yun et al., “Polyphenols isolated from Allium cepa L. induces apoptosis by induction of p53 and suppression of Bcl-2 through inhibiting PI3K/Akt signaling pathway in AGS human cancer cells,” Journal of Cancer Prevention, vol. 19, no. 1, pp. 14–22, 2014. View at Google Scholar
  37. F. McCormick, “Cancer: survival pathways meet their end,” Nature, vol. 428, no. 6980, pp. 267–269, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. G. C. Shore and M. Nguyen, “Bcl-2 proteins and apoptosis: choose your partner,” Cell, vol. 135, no. 6, pp. 1004–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Skommer, D. Wlodkowic, and A. Deptala, “Larger than life: mitochondria and the Bcl-2 family,” Leukemia Research, vol. 31, no. 3, pp. 277–286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. D'Amelio, M. Sheng, and F. Cecconi, “Caspase-3 in the central nervous system: beyond apoptosis,” Trends in Neurosciences, vol. 35, no. 11, pp. 700–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Algeciras-Schimnich, B. C. Barnhart, and M. E. Peter, “Apoptosis-independent functions of killer caspases,” Current Opinion in Cell Biology, vol. 14, no. 6, pp. 721–726, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. J. H. Zheng, A. Viacava Follis, R. W. Kriwacki, and T. Moldoveanu, “Discoveries and controversies in BCL-2 protein-mediated apoptosis,” The FEBS Journal, 2015. View at Publisher · View at Google Scholar
  43. D. L. Vesely, B. Hoffman, and D. A. Liebermann, “Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells,” Oncogene, vol. 26, no. 21, pp. 3041–3050, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Rasul, C. Ding, X. Li et al., “Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB activation, up-regulates the expression of p53, and enhances apoptosis,” Apoptosis, vol. 17, no. 10, pp. 1104–1119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Yang, L. Z. Xu, Z. Q. Liu et al., “Interleukin-13 interferes with activation-induced t-cell apoptosis by repressing p53 expression,” Cellular & Molecular Immunology, 2015. View at Publisher · View at Google Scholar
  46. D. C. Henshall, T. Araki, C. K. Schindler et al., “Activation of Bcl-2-associated death protein and counterresponse of Akt within cell populations during seizure-induced neuronal death,” The Journal of Neuroscience, vol. 22, no. 19, pp. 8458–8465, 2002. View at Google Scholar · View at Scopus
  47. L. Yuan, S. Wei, J. Wang, and X. Liu, “Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-Related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells,” Journal of Agricultural and Food Chemistry, vol. 62, no. 23, pp. 5390–5400, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. B. R. Seo, K.-J. Min, I. J. Cho, S. C. Kim, and T. K. Kwon, “Curcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stability,” PLoS ONE, vol. 9, no. 4, Article ID e95588, 2014. View at Publisher · View at Google Scholar · View at Scopus